US 8735418
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted A61PA61P29/00A61P35/00
Quick answer
US patent 8735418 (Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases) held by Rigel Pharmaceuticals, Inc. expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P35/02, A61P37/06